Tetramethylpyrazine protects rat renal tubular cell apoptosis induced by gentamicin

Nephrol Dial Transplant. 2007 Mar;22(3):732-9. doi: 10.1093/ndt/gfl699. Epub 2006 Nov 28.

Abstract

Background: Gentamicin, a widely used antibiotic for the treatment of bacterial infection, can cause nephrotoxicity. Tetramethylpyrazine (TMP) is a compound purified from the rhizome of Ligusticum wallichi (Chuanxiong) and has been found to protect against ischaemia-reperfusion injury, nephritis and alcohol-induced toxicity in rat kidneys.

Methods: We used rat renal tubular cells (RTCs), NRK-52E, in this study. The cytotoxicity of gentamicin was checked with transferase-mediated deoxyuridine triphosphate nick end-labeling (TUNEL) staining, and the generation of reactive oxygen species was measured using the fluorescent probe 2,7-dichlorofluorescein. We evaluated several apoptotic parameters: cleaved caspase levels, tumour necrosis factor (TNF-alpha) excretion and nuclear factor Kappa B (NF-kappaB) activity. We also examined the TMP protective effect on gentamicin-induced apoptosis in rat kidneys.

Results: The results of this study showed that gentamicin was found to markedly induce apoptosis in NRK-52E cells in a dose-dependent manner; that TMP expressed a dose-dependent protective effect against gentamicin-induced apoptosis; that pre-treatment of the cells with 50 or 100 microM of TMP effectively decreased the reactive oxygen species formation induced by gentamicin; that TMP was found to inactivate the gentamicin-stimulated activities of caspase-3, caspase-8 and caspase-9, to inhibit gentamicin-induced release of cytochrome c, as well as to raise the expression of Bcl-x(L); that TMP inhibited the gentamicin-induced TNF-alpha excretion, and inactivated the transcription factor NF-kappaB; and that the TMP treatment significantly reduced apoptotic injury in rat RTCs.

Conclusions: Based on the results of this study, we suggest that TMP can attenuate gentamicin-induced oxidative stress and apoptotic injury in rat RTCs, and that its character may have therapeutic potential for patients with renal diseases.

MeSH terms

  • Animals
  • Anti-Bacterial Agents / pharmacokinetics
  • Anti-Bacterial Agents / toxicity
  • Apoptosis / drug effects*
  • Blotting, Western
  • Caspase 3 / metabolism
  • Caspase 8 / metabolism
  • Caspase 9 / metabolism
  • Caspase Inhibitors
  • Cytochromes c / drug effects
  • DNA / genetics
  • Disease Models, Animal
  • Electrophoretic Mobility Shift Assay
  • Enzyme-Linked Immunosorbent Assay
  • Gene Expression / drug effects
  • Gentamicins / pharmacokinetics
  • Gentamicins / toxicity*
  • In Situ Nick-End Labeling
  • Kidney Tubules, Proximal / drug effects
  • Kidney Tubules, Proximal / metabolism
  • Kidney Tubules, Proximal / pathology*
  • Ligusticum
  • Male
  • NF-kappa B / antagonists & inhibitors
  • NF-kappa B / metabolism
  • Oxidative Stress / drug effects
  • Pyrazines / pharmacology*
  • Rats
  • Rats, Sprague-Dawley
  • Reactive Oxygen Species / metabolism
  • Reperfusion Injury / metabolism
  • Reperfusion Injury / pathology
  • Reperfusion Injury / prevention & control
  • Tumor Necrosis Factor-alpha / drug effects
  • Tumor Necrosis Factor-alpha / metabolism
  • Vasodilator Agents / pharmacology*
  • bcl-X Protein / drug effects
  • bcl-X Protein / genetics

Substances

  • Anti-Bacterial Agents
  • Bcl2l1 protein, rat
  • Caspase Inhibitors
  • Gentamicins
  • NF-kappa B
  • Pyrazines
  • Reactive Oxygen Species
  • Tumor Necrosis Factor-alpha
  • Vasodilator Agents
  • bcl-X Protein
  • Cytochromes c
  • DNA
  • Caspase 3
  • Caspase 8
  • Caspase 9
  • tetramethylpyrazine